drugset
drugset / Trial / NCT01363752

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

NCT01363752 ↗

Phase 4 Completed 853 enrolled Astellas Pharma Inc
RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to compare the effect of two anti-rejection therapy regimens on kidney function in kidney transplant recipients.

Timeline

Start
2011-03-08
Primary completion
2013-09-18
Completion
2013-09-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Mycophenolate Mofetil Small molecule — Oral
Subject Sirolimus Small molecule — Oral
Subject Tacrolimus Small molecule — Oral

Indications

No indication recorded.